← Vulnerability feed

Vulnerability record · CVE-2025-61940 · published 2 December 2025

CVE-2025-61940: Mirion biodose\/nmis vulnerability

Mirion · Biodose\/Nmis

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

8.7 CVSS 4.0 High EPSS 0.32% · top 77.1% CWE-603 · CWE-603
8.7CVSS 4.0 base score
0.32%EPSS exploitation probability, 30 days
NoNot in CISA KEV
1Affected product versions listed by NVD
1References
25 Sep 2026Last modified by NVD

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:

Affected products

1 vulnerable configurations from NVD's CPE data, grouped by vendor and product.

References

Track CVE-2025-61940 inside VULONE

Watch it alongside the ransomware crews, C2 infrastructure and forum chatter that reference it, query it through the API and pull it into your SIEM over TAXII.

Start free Open in platform

Related vulnerabilities

Same products first, then exploited flaws of the same weakness class.

Source: NIST National Vulnerability Database (record CVE-2025-61940), CISA KEV, FIRST EPSS (scores of 2026-09-27). This page is refreshed as NVD updates the record.